Growth Metrics

Clorox (CLX) EBITDA Margin (2016 - 2026)

Clorox has reported EBITDA Margin over the past 18 years, most recently at 27.9% for Q1 2026.

  • For Q1 2026, EBITDA Margin rose 1645.0% year-over-year to 27.9%; the TTM value through Mar 2026 reached 26.39%, up 1157.0%, while the annual FY2025 figure was 27.7%, 296.0% up from the prior year.
  • EBITDA Margin for Q1 2026 was 27.9% at Clorox, up from 25.76% in the prior quarter.
  • Over five years, EBITDA Margin peaked at 30.64% in Q2 2024 and troughed at 10.81% in Q1 2023.
  • A 5-year average of 14.09% and a median of 11.45% in 2025 define the central range for EBITDA Margin.
  • Biggest five-year swings in EBITDA Margin: plummeted -2225bps in 2023 and later skyrocketed 1924bps in 2024.
  • Year by year, EBITDA Margin stood at 6.71% in 2022, then skyrocketed by 71bps to 11.46% in 2023, then decreased by -18bps to 9.43% in 2024, then skyrocketed by 173bps to 25.76% in 2025, then grew by 8bps to 27.9% in 2026.
  • Business Quant data shows EBITDA Margin for CLX at 27.9% in Q1 2026, 25.76% in Q4 2025, and 20.36% in Q3 2025.